Skip nav

R&D Projects

Confirmed projects database queries

The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.

Call for SR&TD Project Grants - 2017

Oncobiology

PTDC/MED-ONC/28282/2017

Telomeric R-loop-mediated recombination in the alternative lengthening of telomeres pathway: towards designing novel therapeutic avenues for cancer therapy. Bruno Adriano Sousa Silva, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €239,854.

PTDC/MED-ONC/28636/2017

Physiopathology and clinical implications of the RANK c.1386C>T (R450W) mutation in breast cancer patients. Sandra Cristina Cara de Anjo Casimiro, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €239,615.

PTDC/MED-ONC/28660/2017

Targeting Intra-Tumor Heterogeneity as a promising therapeutic strategy for cancer. Ana Rita Grosso, NOVA.ID.FCT - Associação para a Inovação e Desenvolvimento da FCT (NOVA.ID.FCT). €239,479.

PTDC/MED-ONC/29402/2017

Detect, prevent, eradicate: a multi-step strategy to abrogate brain metastasization of breast cancer. Maria Alexandra de Oliveira Silva Braga Pedreira de Brito, FARM-ID, Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento (FARM-ID). €239,860.

PTDC/MED-ONC/30436/2017

How cholesterol favors breast cancer intravasation and metastization. Sérgio Dias, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €190,615.

PTDC/MED-ONC/31565/2017

Origin and consequences of centrosome abnormalities in early human tumorigenesis. Carla Alexandra Mendes Lopes, Fundação Calouste Gulbenkian (FCG). €219,671.

PTDC/MED-ONC/32048/2017

Studying and targeting the non-coding functions of p53 mRNA in carcinogenesis. Marco Candeias, FCiências.ID - Associação para a Investigação e Desenvolvimento de Ciências (Fciências.ID). €232,199.

PTDC/MED-ONC/32222/2017

Using genomics to identify novel targeted therapies in brain metastases. Cláudia Maria Coelho de Faria, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €238,740.